Publication | Closed Access

The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets

Functional SelectivityMedicinePharmacological AgentNeuropharmacologyMptp-treated Common MarmosetsPharmacotherapyNeuroscienceLow DosesDopamine AgonistsDopaminePharmacologyNeuropeptides